Mustang Bio, Inc.
MBIO
$1.13
-$0.07-5.44%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.74M | 3.18M | 3.93M | 4.14M | 6.54M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.74M | 2.57M | 7.58M | 12.55M | 21.44M |
| Operating Income | -1.74M | -2.57M | -7.58M | -12.55M | -21.44M |
| Income Before Tax | -2.34M | -3.28M | -10.71M | -15.75M | -23.42M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.34 | -3.28 | -10.71 | -15.75 | -23.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.34M | -3.28M | -10.71M | -15.75M | -23.42M |
| EBIT | -1.74M | -2.57M | -7.58M | -12.55M | -21.44M |
| EBITDA | -1.65M | -2.43M | -7.16M | -11.88M | -20.53M |
| EPS Basic | -1.26 | -3.14 | -21.31 | -46.07 | -88.15 |
| Normalized Basic EPS | -0.14 | -1.32 | -8.97 | -24.44 | -52.37 |
| EPS Diluted | -1.26 | -3.14 | -21.31 | -46.07 | -88.15 |
| Normalized Diluted EPS | -0.14 | -1.32 | -8.97 | -24.44 | -52.37 |
| Average Basic Shares Outstanding | 14.14M | 8.61M | 5.04M | 2.39M | 1.58M |
| Average Diluted Shares Outstanding | 14.14M | 8.61M | 5.04M | 2.39M | 1.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |